Posted by Michael Wonder on 12 Nov 2020
NICE recommends innovative treatment for severe blood disorder for NHS use
12 November 2020 - Caplacizumab, with plasma exchange and immunosuppression, will be used to treat acute acquired thrombotic thrombocytopenic purpura.
A brand-new treatment – the first for 25 years – for a rare blood disorder has been recommended by NICE for routine use on the NHS.
